Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

853
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
853
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

7.6K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
7.6K
Brain Imaging01:14

Brain Imaging

1.0K
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age-dependent vascular and neurological characteristics of CADASIL are recapitulated in Notch3 mutant zebrafish, implicating a role for type IV collagen in disease progression.

Acta neuropathologica communications·2026
Same author

Ln<sub>3</sub>TCAS<sub>2</sub>-polyethyleneimine supramolecular nanogels: a platform for neutron capture therapy and complementary magnetic resonance imaging (Ln = lanthanide, TCAS = thiacalix[4]arene-<i>p</i>-tetrasulfonate).

Dalton transactions (Cambridge, England : 2003)·2026
Same author

Hide-and-seek molecular navigator targets tumor cell surface thiols by programmable disulfide exchange.

Biomaterials·2026
Same author

PLGA Nanoparticle-Mediated Sustained Release of Fisetin for Intra-Articular Therapy of Temporomandibular Joint Osteoarthritis.

International journal of molecular sciences·2026
Same author

Preterm Birth Increases Susceptibility to Hyperglycemia-Induced Kidney Injury With Sex-Specific Differences in Structural and Molecular Responses.

Endocrinology, diabetes & metabolism·2026
Same author

Measuring nephron number in the healthy and diabetic rat kidney in vivo using MRI without contrast agents.

American journal of physiology. Renal physiology·2026

Related Experiment Video

Updated: Apr 30, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

12.3K

MR imaging techniques for nano-pathophysiology and theranostics.

Kevin M Bennett1, Jun-ichiro Jo2, Horacio Cabral3

  • 1The University of Hawaii at Manoa, Department of Biology, College of Natural Sciences, 2540 Campus Rd., Honolulu, HI 96822 USA.

Advanced Drug Delivery Reviews
|May 3, 2014
PubMed
Summary

Nanoparticle drug delivery systems (nano-DDSs) offer targeted therapy but face challenges in tumors. Nano-pathophysiological imaging helps optimize nano-DDS selection and evaluate drug effects for improved cancer treatment.

Keywords:
ActivatableCancerDDSIn vivo imagingMRIMultimodalNanoparticlesTheranostics

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

8.2K
Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy
07:13

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy

Published on: May 16, 2022

1.8K

Related Experiment Videos

Last Updated: Apr 30, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

12.3K
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

8.2K
Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy
07:13

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy

Published on: May 16, 2022

1.8K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Nanoparticle drug delivery systems (nano-DDSs) enable precise drug delivery and enhanced therapeutic effects.
  • Challenges remain in delivering nano-DDSs to target sites, especially in fibrotic tumors like pancreatic and stomach cancers.
  • Optimizing nanoparticle type and size is crucial for effective delivery.

Purpose of the Study:

  • To introduce the concept of nano-pathophysiological imaging for theranostics.
  • To highlight the importance of high-resolution 3D imaging for visualizing nanoparticle distribution and therapeutic outcomes.
  • To classify nano-DDSs based on carrier materials and discuss their role in nano-pathophysiological MRI.

Main Methods:

  • Classification of nano-DDSs by component carrier materials.
  • Utilizing high-resolution 3D imaging to assess nanoparticle distribution and therapeutic effects in vivo.
  • Developing a strategy for rapid in vivo evaluation of drug effects to guide subsequent therapy.

Main Results:

  • Nano-DDSs can achieve higher local drug concentrations, magnifying therapeutic effects.
  • Interstitial cells and fibrosis in tumors can hinder nanoparticle penetration.
  • Nano-pathophysiological imaging provides a method to visualize and guide nanoparticle-based therapies.

Conclusions:

  • Nano-pathophysiological imaging is a promising theranostic strategy for optimizing cancer treatment.
  • Selecting appropriate nano-DDSs and rapidly evaluating their efficacy in vivo are critical for successful therapy.
  • Further research into nano-DDS classification and imaging techniques will advance personalized cancer therapy.